Pacific Biosciences: Longer Reads, But Shorter Patience (Downgrade)

2025-12-18 11:20:17 ET

Although the shares of long-read sequencing specialist Pacific Biosciences of California, Inc. ( PACB ) (“PacBio”) have done better of late, rising more than 25% since my last "Buy" update in February and outperforming both Illumina ( ILMN ) and Oxford Nanopore ( ONTTF ) (ONT.L), this company is still a long way from being out of the woods, let alone on a stable and sustainable growth trajectory....

Read the full article on Seeking Alpha

For further details see: